Video

Alan Rapoport, MD

Publish date: July 12, 2018

At the American Headache Society’s 60th Annual Scientific Meeting, Dr. Alan Rapoport summarizes a poster he presented regarding ZOTRIP, Zosano Pharma’s zolmitriptan patch.

 

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel .

Recommended Reading

Does Migraine Transiently Open the Blood–Brain Barrier?
MDedge Neurology
Erenumab May Control Migraines When Other Preventives Have Failed
MDedge Neurology
Noninvasive Neurostimulator Shows Efficacy in Episodic Migraine
MDedge Neurology
FDA approves Aimovig for migraine prevention
MDedge Neurology
FDA Updates
MDedge Neurology
How Common Are Comorbidities in Chronic Versus Episodic Migraine?
MDedge Neurology
Ubrogepant May Treat Acute Migraine Attacks Effectively
MDedge Neurology
Eptinezumab May Reduce Migraine Frequency in Patients With Chronic and Episodic Migraine
MDedge Neurology
Fremanezumab May Be an Effective Preventive Treatment for Chronic Migraine
MDedge Neurology
25+ Years of Migraine
MDedge Neurology